Literature DB >> 10331848

Alpha coefficient of dose-response for chromosome translocations measured by FISH in human lymphocytes exposed to chronic 60Co gamma rays at body temperature.

W A Hsieh1, W Deng, W P Chang, N Galvan, C L Owens, D P Morrison, K L Gale, J N Lucas.   

Abstract

PURPOSE: To measure the alpha coefficient, the initial slope of the translocation dose-response curve, for 60Co gamma-rays in human lymphocytes.
MATERIALS AND METHODS: Human lymphocytes were exposed to 0, 0.32, 0.62 and 0.92 Gy of chronic 60Co gamma-rays under conditions that reduce the metabolic stress to the cells. Chromosome translocation frequencies were measured using fluorescence in situ hybridization with a whole-chromosome probe cocktail specific for chromosomes 1, 2, 4 (orange) and 3, 5, 6 (green).
RESULTS: A total of 72,383 metaphases were analysed (33,429 in exposed cells) in two individuals. The shape of the dose-response curves for translocations was linear, and alpha coefficient was measured as 0.024 +/- 0.002 translocations per cell per Gy for the combined data for two 24 year old male donors.
CONCLUSION: The alpha coefficients measured after chronic exposure were in good agreement with that reported in the literature for acute, low-dose exposure of human lymphocytes to 60Co gamma-rays.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10331848     DOI: 10.1080/095530099140357

Source DB:  PubMed          Journal:  Int J Radiat Biol        ISSN: 0955-3002            Impact factor:   2.694


  2 in total

Review 1.  The role of dose rate in radiation cancer risk: evaluating the effect of dose rate at the molecular, cellular and tissue levels using key events in critical pathways following exposure to low LET radiation.

Authors:  Antone L Brooks; David G Hoel; R Julian Preston
Journal:  Int J Radiat Biol       Date:  2016-06-07       Impact factor: 2.694

2.  30 years follow-up and increased risks of breast cancer and leukaemia after long-term low-dose-rate radiation exposure.

Authors:  Wan-Hua Hsieh; I-Feng Lin; Jung-Chun Ho; Peter Wushou Chang
Journal:  Br J Cancer       Date:  2017-10-03       Impact factor: 7.640

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.